Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Immunology | Family Medicine
 Disease Category: Allergies & Asthma
Location: United States, FL

Trial Information

12 week dose ranging study to evaluate the efficacy and safety of Fluticasone Propionate Spiromax administered twice daily compared with placebo in adolescents and adults with persistent asthma uncontrolled on non-steroidal therapy

12 weeks study requiring 6 morning visits. Subjects should be without inhaled corticosteroids for 6 weeks prior to the screening visit.

Patient Inclustion Criteria:

  • Age: > 12 years old and older
  • General good health
  • Prior asthma diagnosis
  • Current therapy: short acting bronchodilator

Patient Exclusion Criteria:

  • History of life-threatening asthma
  • Asthma exacerbations within 3 months of screening
  • History of glaucoma, cataracts, malignancy, COPD, hepatitis B or C
  • History of allergy to milk protein

Florina Shawwaf, site director
Florida Center for Allergy and Asthma Research
21150 Biscayne Blvd.
# 408
Aventura, FL 33180
Phone: 305-932-3252
Fax: 305-933-0928
Email: fshawwaf@florida-allergy.com

View Map

Research Center Information: Florida Center for Allergy and Asthma Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.